Curtis Rambaran – Biography
Last update: March 16, 2026Executive profile
Curtis was Global Team Leader Clinical Development & Translational Medicine at Daiichi Sankyo, and Director, Cardiovascular Clinical Development at GSK. Curtis served as Vice President and Head of Clinical Sciences at Silence Therapeutics.
Curtis Rambaran is currentlyChief Medical Officer at Silence Therapeutics - View - Silence Therapeutics org chart
Create your alert
to follow the career of Curtis Rambaran.
Education
Curtis Rambaran has a Bachelor of Medicine & Surgery from University of the West Indies and a Postgraduate Research Doctorate in Cardiovascular Medicine from King's College London.
They have also studied at University of the West Indies :
Find more alumni from University of the West Indies
They have also studied at King's College London :
Find more alumni from King's College London
More about Curtis Rambaran
Selected links
Do you need to know more about Curtis Rambaran? More results.
Participate
Social media
- Curtis Rambaran on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Curtis Rambaran
The colleagues of Curtis Rambaran
Company Colleagues
- At Silence Therapeutics, Curtis Rambaran has 24 colleagues including Ian Ross (Chairman & Interim CEO), Dave Lemus (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Curtis Rambaran has 22,991 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Curtis Rambaran.
Get in Touch
Here are a few tips for establishing great contacts.
